Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Boehringer Ingelheim shares their initiatives on systematically operationalizing patient engagement within their drug development lifecycle. Case examples will be shared that demonstrate: • How they are building patient insights into their development and commercial programs • How patient perspective differs based on region culture, and how they incorporate those considerations
Hilary Wilson, Director, Patient Engagement, Boehringer Ingelheim
Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org
